# FDA Inspection 826054 - Regenerative Biologics, Inc. - April 08, 2013

Source: https://www.globalkeysolutions.net/records/fda_inspections/regenerative-biologics-inc/db2217ed-4cef-4d3d-bff5-5934809df35a
Source feed: FDA_Inspections

> FDA Inspection 826054 for Regenerative Biologics, Inc. on April 08, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 826054
- Company Name: Regenerative Biologics, Inc.
- Inspection Date: 2013-04-08
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 898074 - 2014-09-30](https://www.globalkeysolutions.net/records/fda_inspections/regenerative-biologics-inc/e28e45eb-4ec1-48c9-ac44-41cfefbdeee6)

Company: https://www.globalkeysolutions.net/companies/regenerative-biologics-inc/d185c122-a606-4c09-9b4d-389d24ee93f1

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d